This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
FANG, which stands for Facebook, Amazon, Netflix and Google, was coined by the "Mad Money" host himself to refer to the group of high-performing tech stocks. But given Thursday's market moves, Cramer thinks WANG – Walmart, Apple, Netflix and Google – might be the new group to watch.
LRCX GEC GE RDS.B RDS.A RDSB RDSA MTCH EBIX AMAT RYDBF AEP GNE NS RYDAF
Royal Dutch Shell: "Everyone hates the oils, which means it is time to buy the oils because oil's going from $70 to $80. Everybody is all crazy about them. Royal Dutch is really good."
FOXF LRCX RDS.B RDS.A RDSB SRPT RDSA SNEJF MPC DNR EBIX AMAT RYDBF URI NS SNE RYDAF
Chicago, IL – August 9, 2018 – Zacks Equity Research highlights Micron (MU - Free Report) as the Bull of the Day, Ultra Clean Holdings (UCTT - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onThe Scotts Miracle-Gro Company (SMG - Free Report) , GW Pharmaceuticals (GWPH - Free Report) , Innovative Industrial Properties (IIPR - Free Report) , Molson Coors (TAP - Free Report) and Constellation Brands (STZ - Free Report) .
LRCX STZ.B UCTI CXO STZ TRTN MPC CGC GLUU TWMJF IIPR ROSEU TPX.B WEED HEAR GWP FG UCTT SMG ROSE
Good day, ladies and gentlemen, and welcome to NanoString 2018 Second Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call will be recorded.
As the US launches tariffs against China, the chip sector is set to be hit to the tune of $613m. This seems a relatively small number when compared to the sector's total sales of ~$483bln. The worry is that China could retaliate and ban US companies from selling chips. This sounds a bit outrageous. In a report that China is banning Micron Technology’s (MU) from selling some products in China, Micron Management noted that the injunction would only hit sales by 1% next quarter.
Lam Research (NASDAQ:LRCX) has had quite the year. The stock is up more than 25% from its lows, but it is also down more than 20% from its highs. The company has been growing its business quite nicely and has been very shareholder-friendly, returning plenty of capital. With the stock in the middle of this year's trading range, we review if the company is worth making an investment in.
WallStars show positive broker target price upsides. Top "safer" dividend Technology WallStar, Western Digital, showed 51.55% gains. Top ten averaged 27% per Broker estimates plus dividends. All leaders signaled oversold.
WSO LRCX WDC STX TEL KLAC AMAT AVGO DTST CSCO QCOM INTC MXIM
WallStars show positive broker target price upsides. The top WallStar Technology ten by broker-estimated net gains, Daktronics, Benchmark Electronics, Lam Research, Camtek, Richardson Electronics, Broadcom, Monotype Imaging Holdings, Xerox, PCTEL, Inc., and Western Digital, averaged 35.86%, calculated as on 8/1/18.
IBM LRCX WSO TYPE RELLB WDC STX BHE XRX CAMT DAKT PCTI AVGO NOK RELL TESS QCOM
FREMONT, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Lam Research Corporation (Nasdaq: LRCX) today announced its upcoming investor conference schedule:
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET